Clinical Trial Update: A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a cell therapy in acute kidney injury patients on continuous renal replacement therapy, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Cell Therapy (Sen-xxx) - Sentien Biotechnologies

Snippet

Sponsor: Sentien Biotechnologies, Inc. | Conditions: Acute Kidney Injury | Phase 1, Phase 2 | Status: UNKNOWN